Tower Research Capital (TRC)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,941
| Closed | -$372K | – | 6925 |
|
|
2022
Q2 | $372K | Buy |
4,941
+3,774
| +323% | +$284K | 0.01% | 1323 |
|
|
2022
Q1 | $31K | Sell |
1,167
-5,317
| -82% | -$141K | ﹤0.01% | 3130 |
|
|
2021
Q4 | $309K | Buy |
6,484
+1,614
| +33% | +$76.9K | 0.01% | 1461 |
|
|
2021
Q3 | $324K | Buy |
4,870
+2,838
| +140% | +$189K | 0.01% | 1323 |
|
|
2021
Q2 | $158K | Sell |
2,032
-1,336
| -40% | -$104K | ﹤0.01% | 2097 |
|
|
2021
Q1 | $319K | Buy |
3,368
+686
| +26% | +$65K | 0.01% | 1625 |
|
|
2020
Q4 | $327K | Buy |
2,682
+1,586
| +145% | +$193K | 0.01% | 1326 |
|
|
2020
Q3 | $96K | Sell |
1,096
-4,041
| -79% | -$354K | ﹤0.01% | 3179 |
|
|
2020
Q2 | $332K | Buy |
+5,137
| New | +$332K | 0.01% | 1362 |
|
|
2020
Q1 | – | Sell |
-566
| Closed | -$35K | – | 4239 |
|
|
2019
Q4 | $35K | Sell |
566
-982
| -63% | -$60.7K | ﹤0.01% | 1569 |
|
|
2019
Q3 | $58K | Buy |
1,548
+942
| +155% | +$35.3K | ﹤0.01% | 1690 |
|
|
2019
Q2 | $25K | Buy |
+606
| New | +$25K | ﹤0.01% | 2036 |
|